Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study

Field Value
Model ID09-047-02
Model NameLosartan Intervention For Endpoint (LIFE) Risk Score - Mortality
Pubmed ID20001655
First AuthorKjeldsen
JournalBlood Pressure
Year2009
TitlePredictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Primary Index ConditionPopulation Sample
Secondary Index ConditionHypertension
OutcomeMortality
Model Sample Size9193
Cohort Sample Size9193
Number of Events438
Follow-Up DurationLong (>6 months)
AUROC0.795
Calibration Reported1
CovariatesAge in non-smokers (per 10 years); Current smoker; History of atrial fibrillation; History of stroke or transient ischemic attack; Log urinary albumin:creatinine ratio (per 10-fold); Exercise >30 min twice/week; LVH by Cornell product (per 1000 mm-s); Male sex; Serum glucose (mmol/l); Age in current smokers (per 10 years); Prior ischemic heart disease; Serum creatinine (per 10 umol/l)
Mesh TermsTo be updated
Number of Validations0

External Validations